Mycobacterium marinum: an increasingly common opportunistic infection in patients on infliximab.
Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.The American Journal of Gastroenterology (impact factor: 7.28). 08/2012; 107(8):1268-9. DOI:10.1038/ajg.2012.118 pp.1268-9
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.